Advanced search

Authors whose works are in public domain in at least one jurisdiction

List of works by Annette J. Vangsted

1-50 of 56 results

View this query on the Wikidata Query Service
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR−/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma

scientific article published on 01 December 2010
Genome-wide association study identifies multiple susceptibility loci for multiple myeloma

scientific article
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial

scientific article published on October 2010
Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma

scientific article
Polymorphisms in the genes ERCC2, XRCC3 and CD3EAP influence treatment outcome in multiple myeloma patients undergoing autologous bone marrow transplantation

article
Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

scientific article published in Nature Communications
Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study

scientific article published on 29 December 2015
The polymorphism IL-1β T-31C is associated with a longer overall survival in patients with multiple myeloma undergoing auto-SCT

scientific article published on 10 November 2008
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database

scientific article published on 2 February 2015
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length

scientific article published on 6 August 2014
Genetic variations in multiple myeloma II: association with effect of treatment

scientific article
Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.

scientific article
Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma

scientific article published on 31 January 2012
Single nucleotide polymorphisms in the promoter region of the IL1B gene influence outcome in multiple myeloma patients treated with high-dose chemotherapy independently of relapse treatment with thalidomide and bortezomib

article
A functional polymorphism in the promoter region of the IL1B gene is associated with risk of multiple myeloma

article
A polymorphism in NFKB1 is associated with improved effect of interferon-{alpha} maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support

scientific article published on September 2009
No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma

scientific article published on 4 August 2010
The Danish National Multiple Myeloma Registry

scientific article
Gastrin releasing peptide GRP(14-27) in human breast cancer cells and in small cell lung cancer

scientific article published on October 1991
Oxytocin and vasopressin binding sites in human and bovine ovaries

scientific article published on 01 December 1990
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma

scholarly article
GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis

scientific article
Genetic variations in multiple myeloma I: effect on risk of multiple myeloma

scientific article
Improved survival of multiple myeloma patients with late relapse after high-dose treatment and stem cell support, a population-based study of 348 patients in Denmark in 1994-2004.

scientific article published on 05 May 2010
The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage disequilibrium mapping in RAI and CD3EAP

scientific article published on 03 November 2010
Production of gastrin-releasing peptide-(18-27) and a stable fragment of its precursor in small cell lung carcinoma cells

scientific article published on June 1990
Genetic Variants and Multiple Myeloma Risk: IMMEnSE Validation of the Best Reported Associations--An Extensive Replication of the Associations from the Candidate Gene Era

article
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

scientific article published on 22 May 2020
Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium

scientific article published on 22 June 2015
Induction of CD3 delta epsilon omega by phorbol 12-myristate 13-acetate.

scientific article
Synergy of two human endogenous retroviruses in multiple myeloma.

scientific article published on 24 June 2015
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.

scientific article published on 18 July 2016
Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients

scientific article published on 9 December 2015
Drug response prediction in high-risk multiple myeloma

scientific article
Identification of miRSNPs associated with the risk of multiple myeloma.

scientific article
Polymorphisms in the heparanase gene in multiple myeloma association with bone morbidity and survival

article
Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients

scientific article published on 06 August 2018
Serological tumor markers for small cell lung cancer and their therapeutic implications

scientific article published on 01 August 1994
Genetic variants in theP2RX7gene are associated with risk of multiple myeloma

article
Monoclonal antibodies for diagnosis and potential therapy of small cell lung cancer--the ganglioside antigen fucosyl-GM1.

scientific article published on January 1993
Gastrin releasing peptide (GRP) is present in a GRP(1–27) form in anterior pituitary cells of the guinea pig

scientific article published on 01 July 1989
Gene expression risk signatures maintain prognostic power in multiple myeloma despite microarray probe set translation.

scientific article published on 29 March 2016
A common genetic variant in 19q13·3 is associated with outcome of multiple myeloma patients treated with Total Therapy 2 and 3.

scientific article published on 16 November 2015
Early relapsed disease of multiple myeloma following up-front HDM-ASCT: a study based on the Danish Multiple Myeloma Registry in the period 2005 to 2014.

scientific article published on 22 February 2018
Serum immunoassay of a small cell lung cancer associated ganglioside: development of a sensitive scintillation proximity assay

scientific article published on 01 December 1992
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danis

scientific article published on 09 June 2020
Deciphering the genetics and mechanisms of predisposition to multiple myeloma

The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

scientific article published on 28 September 2018
Germline variants at SOHLH2 influence multiple myeloma risk

scientific article published on 19 April 2021
Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients

scientific article published on 29 October 2018

Paulina is supported by:

About Paulina

Help